![Simon Green](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 36 617 $ in data 31/05/2026
Simon P.
Green is the founder of Immunosis Pty Ltd. since 2015, holding the title of Chief Executive Officer.
Current jobs include Independent Non-Executive Director at Syntara Ltd. since 2022, Independent Non-Executive Director at Clover Corp.
Ltd. since 2020, and Venture Partner at Bioscience Managers Pty Ltd. since 2020.
Former jobs include Independent Non-Executive Director at Acrux Ltd. from 2016 to 2019 and Senior Vice President-Research & Development at CSL Behring GmbH from 2008 to 2012.
Education includes a doctorate from the University of Melbourne conferred in 1992 and an undergraduate degree from Monash University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/07/2025 | 56.234 ( 0,03% ) | 36 617 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| CLOVER CORPORATION LIMITED | Direttore/Membro del Consiglio | 20/10/2020 |
| SYNTARA LIMITED | Direttore/Membro del Consiglio | 16/12/2022 |
Immunosis Pty Ltd.
 Immunosis Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Amministratore Delegato | 01/11/2015 |
Bioscience Managers Pty Ltd.
 Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Investitore di Private Equity | 01/05/2020 |
| Società | Posizione | Fine |
|---|---|---|
| ACRUX LIMITED | Direttore/Membro del Consiglio | 01/01/2019 |
CSL Behring GmbH
 CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Direttore Tecnico/Scientifico/R&S | 01/01/2012 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 8 |
|---|---|
Syntara Ltd.
 Syntara Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and wholesales pharmaceutical products for respiratory disorders | Health Technology |
Clover Corp. Ltd.
 Clover Corp. Ltd. Pharmaceuticals: OtherHealth Technology Produces and sells tuna oil and encapsulated products | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Monash University
 Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acrux Ltd.
 Acrux Ltd. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
CSL Behring GmbH
CSL Behring GmbH Pharmaceuticals: MajorHealth Technology Manufactures plasma protein bio therapeutics for the treatment of rare and major diseases | Health Technology |
Bioscience Managers Pty Ltd.
Bioscience Managers Pty Ltd. Investment ManagersFinance Bioscience Managers invests in both public and private companies located in Asia, Australia and New Zealand. The firm focuses on healthcare and life sciences sectors. It participates in early and growth stage capital transactions. | Finance |
Immunosis Pty Ltd.
Immunosis Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
